All treatments
Treatment
Methylone - 50 mg - capsule clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
This study, IMPACT-1, is looking into a new medication called Methylone for people with Post-Traumatic Stress Disorder (PTSD). It's an early-stage study to see if it's safe and how well it might work to reduce symptoms.
For: Post-Traumatic Stress Disorder (PTSD)Ireland - Ongoing, recruitingTherapeutic exploratory (Phase II)
A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments with Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
This study is looking at a new medicine called Methylone for people with Post-Traumatic Stress Disorder (PTSD). It aims to see if it helps reduce symptoms and if it's safe over a long period, up to a year, for adults.
For: Post-Traumatic Stress DisorderIreland